Ortho-Clinical Diagnostics

From Wikipedia, the free encyclopedia

Ortho-Clinical Diagnostics is a Johnson & Johnson company that makes in vitro diagnostics products. It was created following Johnson and Johnson's acquisition of Eastman Kodak's Clinical Diagnostics Division in 1994 (to form Johnson & Johnson Clinical Diagnostics), which was then merged with Ortho Diagnostic Systems in 1997. Their corporate offices are in Raritan, New Jersey, while their main research facility is in Rochester, New York. The business has two major segments: Transfusion Medicine which is involved in screening human blood, and Clinical Laboratories, which does a variety of chemical testing.

[edit] See also

Ortho-McNeil Pharmaceutical

[edit] External links

Ortho-Clinical Diagnostics

v • d • e Johnson & Johnson William C. Weldon, Chairman & CEO Past CEOs and presidents: Robert Wood Johnson I • James Wood Johnson • Robert Wood Johnson II • Robert Wood Johnson III • Philip B. Hofmann • Richard B. Sellars • James E. Burke • Ralph S. Larsen Selected subsidiaries ALZA Corporation • Centocor • Cilag • DePuy, Inc. • Ethicon Endo-Surgery, Inc. • Ethicon, Inc. • Independence Technology, LLC • J&J PRD •Janssen Pharmaceutica • LifeScan • McNeil Consumer & Specialty Pharmaceuticals • Ortho-McNeil Pharmaceutical • Ortho-Neutrogena • Penaten • Tibotec Major brands Acuvue • Aveeno • Band-Aid • Carefree • Clean & Clear • Johnson's Baby • K-Y • Neutrogena • OneTouch • Rembrandt • Stayfree • Tylenol Annual revenue: $53.3 billion USD ▲ 5.6% Annual income: $11.1 billion USD ▲ 9.9% (FY 2006) · Employees: 116,200 · Stock symbol: NYSE: JNJ · Website: www.jnj.com

This article or section needs sources or references that appear in reliable, third-party publications. Primary sources and sources affiliated with the subject of the article are generally not sufficient for a Wikipedia article. Please include more appropriate citations from reliable sources, or discuss the issue on the talk page. This article has been tagged since October 2007.

This article lacks information on the notability of the subject matter. Please help improve this article by providing context for a general audience, especially in the lead section. (October 2007)